Hanmi/Aptose’s AML Contender Shows Early Promise

Oral Myeloid Kinome Inhibitor Set For Expansion Trials

AML
Hanmi’s AML Candidate Nears Registrational Studies • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anticancer

More from Therapy Areas